Clinical Trials Browser

Phase 2 × Brain Neoplasms × adagrasib × Clear all

NCT03994796 2026-03-04

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Phase 2 Suspended

Brain Neoplasms, Neoplasm Metastasis